Nathan, P. D., Giacomo, A. M. D., Piulats, J. M., Conza, G. D., Hammett, T., Kaur, P., Tonge, K., Veen, L. A. V. D., Lahn, M. M. F. (2025). A phase II randomised study to evaluate the antitumour activity of roginolisib, a novel non-ATP competitive and allosteric modulator inhibiting PI3Kδ, in patients with metastatic uveal melanoma (OCULE-01).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps9613